Replies to post #29434 on Marijuana - Public Weed Stocks & Analysis (WEED)

[DollarsOnPennies]

$NMUS Weekly - NEMUS Bioscience, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of cannabis-based therapeutics for global markets with significant unmet medical needs. Utilizing certain proprietary technology licensed from the University of Mississippi, NEMUS is working to develop novel ways to deliver cannabis-based drugs for specific indications, with the aim of optimizing the clinical effects of such drugs, while limiting the potential adverse events. NEMUS's strategy is not limited to the sole use of either natural or synthetic inputs.